Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. GCTK
stocks logo

GCTK

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Valuation Metrics

The current forward P/E ratio for GlucoTrack Inc (GCTK.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess GlucoTrack Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

GCTK News & Events

Events Timeline

(ET)
2025-08-06
08:38:59
GlucoTrack appoints David Hirsh as medical director, cardiology
select
2025-07-08 (ET)
2025-07-08
08:37:20
GlucoTrack announces repurchase of Series A warrants
select
2025-06-25 (ET)
2025-06-25
08:41:43
GlucoTrack announces study of CBGM met all primary endpoints
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
2.0
09-15Benzinga
Major Stocks Including New Mountain Finance, Texas Instruments, and Analog Devices Decline in Monday's Pre-Market Trading

  • U.S. Stock Futures: U.S. stock futures rose this morning, with the Dow futures increasing by over 50 points, while several stocks, including New Mountain Finance Corporation, experienced significant declines in pre-market trading.

  • Stock Movements: New Mountain Finance shares fell 4.4% after a downgrade by B of A Securities, while other stocks like Kindly MD and aTyr Pharma saw sharp declines of 37.1% and 19.7%, respectively, following previous gains.

[object Object]
Preview
8.5
09-15Benzinga
Check-Cap Shares Surge 183%; Discover 20 Stocks Making Moves in Premarket Trading

  • Check-Cap Ltd Merger Announcement: Check-Cap Ltd's shares surged 183% in pre-market trading following the announcement of a definitive merger agreement with MBody AI, which Chairman David Lontini described as a strategic move into a high-growth industry.

  • Other Notable Pre-Market Movements: Several stocks experienced significant pre-market trading changes, including Helius Medical Technologies (up 163.2%), InnSuites Hospitality Trust (up 118%), and AtlasClear Holdings (up 69.5%), while ECD Automotive Design and Sidus Space saw declines of 27.2% and 26.3%, respectively.

[object Object]
Preview
4.5
09-13Benzinga
Dow Drops 200 Points as US Consumer Sentiment Declines in September

  • U.S. Stock Market Performance: The Dow Jones index fell over 200 points, down 0.44%, while the NASDAQ rose 0.41% and the S&P 500 gained 0.01%. Utilities stocks increased by 0.5%, but materials stocks dropped by 0.6%.

  • Consumer Sentiment Decline: The University of Michigan consumer sentiment index decreased to 55.4 in September from 58 in August, falling short of market expectations.

  • Notable Stock Movements: Allied Gaming & Entertainment shares surged 113% after announcing a Bitcoin and Ethereum investment, while GlucoTrack, Inc. rose 80% following a stock purchase agreement. Conversely, Next Technology Holding Inc. shares plummeted 54% due to a reverse stock split.

  • Global Market Trends: European shares were mixed, with the eurozone's STOXX 600 slightly up, while Asian markets mostly closed higher, led by Japan's Nikkei 225 gaining 0.89%.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is GlucoTrack Inc (GCTK) stock price today?

The current price of GCTK is 5.98 USD — it has increased 3.28 % in the last trading day.

arrow icon

What is GlucoTrack Inc (GCTK)'s business?

Glucotrack, Inc. is focused on the design, development, and commercialization of technologies for people with diabetes. The Company is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. It has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The Company has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.

arrow icon

What is the price predicton of GCTK Stock?

Wall Street analysts forecast GCTK stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for GCTK is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is GlucoTrack Inc (GCTK)'s revenue for the last quarter?

GlucoTrack Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

arrow icon

What is GlucoTrack Inc (GCTK)'s earnings per share (EPS) for the last quarter?

GlucoTrack Inc. EPS for the last quarter amounts to -4.64 USD, decreased -99.57 % YoY.

arrow icon

What changes have occurred in the market's expectations for GlucoTrack Inc (GCTK)'s fundamentals?

The market is revising No Change the revenue expectations for GCTK for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 22.29%.
arrow icon

How many employees does GlucoTrack Inc (GCTK). have?

GlucoTrack Inc (GCTK) has 11 emplpoyees as of December 05 2025.

arrow icon

What is GlucoTrack Inc (GCTK) market cap?

Today GCTK has the market capitalization of 5.37M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free